DUX4 and facioscapulohumeral muscular dystrophy: To investigate a disease-modifying drug for FSHD, we generated a novel gapmer ASO for the human DUX4 sequence, MT-DUX4-ASO, which was selected from the screening of several hundreds of candidates through in vitro and in vivo experiments such as those described below (data not included in this article).